[ad_1]
“We do not expect investors to give Ford a pass” on the car maker’s higher-than-expected second-quarter warranty costs, says J.P. Morgan analyst Ryan Brinkman.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...